Allclenz® Wound Cleanser

Wound cleanser indicated for the use in full and partial thickness wounds.

Offer available for: licensing

Pharmaceutical form and dosage: Liquids

Type:

- Devices
- FP (finished products)
- OTC (over the counter drugs)

Therapeutic target:

- Dermatology
- Geriatrics

Action: Branded product currently marketed as a Medical Device in the United States.

Full Description:
Allclenz® is a clear, moisturizing, non-ionic surfactant wound cleanser containing Poloxamer 188, sorbitol, purified water, Coca Phosphatidly Dimonium Chloride, Potassium Phosphate Monobasic, DMDM Hydantoin and Citric Acid or Sodium Hydroxide.

The product is specifically formulated for the cleansing of Stage I-IV pressure ulcers, stasis ulcers, diabetic ulcers, foot ulcers, post-surgical wounds, first and second degree burns, cuts, abrasions and minor irritations of the skin.

Availability and Market information:

Status:

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- United States of America
- Canada

Market information
First on the market in: United States of America

Other Market Info: Available for licensing and distribution outside the United States, Canada, and Mexico.

  Contact for this offer: Jay Nisbet